DrugPatentWatch Database Preview
Quagen Company Profile
» See Plans and Pricing
What is the competitive landscape for QUAGEN, and what generic and branded alternatives to QUAGEN drugs are available?
QUAGEN has nine approved drugs.
Drugs and US Patents for Quagen
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Quagen | PROPYLTHIOURACIL | propylthiouracil | TABLET;ORAL | 080154-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
Quagen | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | TABLET;ORAL | 040673-002 | Mar 5, 2008 | AB | RX | No | No | Start Trial | Start Trial | ||||
Quagen | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | SYRUP;ORAL | 212266-001 | May 16, 2019 | OTC | No | No | Start Trial | Start Trial | |||||
Quagen | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | SOLUTION;ORAL | 213567-002 | Jun 4, 2020 | AA | RX | No | No | Start Trial | Start Trial | ||||
Quagen | HALOBETASOL PROPIONATE | halobetasol propionate | OINTMENT;TOPICAL | 213560-001 | Oct 6, 2020 | AB | RX | No | No | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.